• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Presenting on the Emerging Growth Conference 74 Day 1 on August 21 Register Now

    8/20/24 7:00:00 AM ET
    $CIA
    $CVKD
    $ELUT
    $EUDA
    Life Insurance
    Finance
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $CIA alert in real time by email

    MIAMI, Aug. 20, 2024 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 74th Emerging Growth Conference on August 21 – 22, 2024.

    The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth.

    Register for the Conference here.

    Submit Questions for any of the presenting companies to:

    [email protected]

    For updates, follow us on Twitter

    Sponsors:

    QuoteMedia - Keep Investors Informed with Dynamic Plug and Play IR Solutions

    (844) 485-8200

    [email protected]

    QuoteMedia.com

    ProCore Advisory - Unleashing the power of strategic investor relations for public and pre-IPO companies

    (832)-847-1327

    [email protected]

    www.procoreadvisory.com

    Day 1

    August 21, 2024

    8:45

    Virtual Lobby opens.

    Register for the Conference. If you already registered, go back to the registration link and click "Already registered" and enter your email.

    9:00

    Introduction

    9:05 – 9:35

    EUDA Health Holdings Limited, (NASDAQ:EUDA)

    Keynote speaker: Kelvin Chen, CEO

    10:50 - 11:20

    BlueRush, Inc. (OTCQB:BTVRF) (TSXV:BTV)

    Keynote speaker: Steve Taylor, CEO

    11:25 - 11:55

    iQSTEL Inc. (OTCQX:IQST)

    Keynote speaker: Leandro Jose Iglesias, Co-Founder, Chairman, President & CEO

    12:35 - 1:05

    Nextech3D.ai or the "Company," (OTCQX:NEXCF) (CSE:NTAR)

    Keynote speaker: Evan Gappelberg Founder, CEO & Chairman

    1:10 - 1:40

    Nova Minerals Limited (NASDAQ:NVA) (OTC:NVAAF) (ASX: NVA)

    Keynote speakers: Christopher Gerteisen – CEO & Executive Director

    1:45 - 2:15

    Pure Cycle Corporation (NASDAQ:PCYO)

    Keynote speaker: Mark Harding, President

    2:20 – 2:50

    Peraso Inc. (NASDAQ:PRSO) 

    Keynote speaker: Ronald Glibbery, Co-Founder, CEO & Director

    2:55 – 3:05

    Elutia, Inc. (NASDAQ:ELUT)

    Keynote speaker: Dr. Randy Mills, President & CEO

    3:10 - 3:20

    Ascend Wellness Holdings Inc. (OTCQX:AAWH) 

    Keynote speaker: John Hartman, CEO

    3:25 - 3:35

    AseptiScope, Inc.

    Keynote speaker: Scott W Mader – Founder & CEO

    3:40 – 3:50

    BlockchainK2 Corp. (OTCQB:BIDCF) (TSXV:BITK) 

    Keynote speaker: Scott Brooks, CEO of RealBlocks

    3:55 – 4:05

    Cadrenal Therapeutics, Inc. (NASDAQ:CVKD)

    Keynote speaker: Mr. Quang X. Pham, Chairman & CEO

    4:10 – 4:20

    GeoVax Labs, Inc. (NASDAQ:GOVX)

    Keynote speaker: David Dodd, Chairman, President / CEO

    4:25 – 4:35

    22nd Century Group, Inc. (NASDAQ:XXII)

    Keynote speaker: Lawrence D. Firestone, Chairman & CEO

    4:40 – 4:50

    Sigyn Therapeutics, Inc. (OTCQB:SIGY)

    Keynote speaker: James Allen Joyce, CEO

    4:55 – 5:05

    CytoMed Therapeutics, Ltd. (NASDAQ:GDTC)

    Keynote speaker: Peter Choo, Chairman

    Day 2

    August 22, 2024

    8:45

    Virtual Lobby opens.

    Register for the Conference. If you already registered, go back to the registration link and click "Already registered" and enter your email.

    9:00

    Introduction

    9:05 – 9:35

    SunCar Technology Group, Inc. (NASDAQ:SDA)

    Keynote speakers: Breaux Walker, GM, International

    9:40 – 10:10

    Bioxytran, Inc. (OTCQB:BIXT) 

    Keynote speakers: Mike Sheikh, Executive Vice President Business Development

    10:15 – 10:45

    Intelligent Bio Solutions Inc. (NASDAQ:INBS)

    Keynote speakers: Harry Simeonidis, President / CEO, Spiro Sakiris, CFO, and Anna Turkington

    10:50 - 11:20

    Citizens, Inc. (NYSE:CIA)

    Keynote speakers: Jon Stenberg, President / CEO, and Jeff Conklin, CFO

    11:25 - 11:55

    Interstellar Communication Holdings

    Keynote speakers: Seda Hewitt, Space Ambassador, Harri Laitinen, CEO of Planix Oy., and Lijie Zhu, Founder and managing director of Dragon Gate Investment Partners

    12:00 - 12:30

    Gossamer Bio, Inc. (NASDAQ:GOSS)

    Keynote speaker: Bryan Giraudo, CFO & COO

    1:10 - 1:40

    Regen BioPharma Inc. (OTC:RGBP) 

    Keynote speakers: David Koos, President / CEO, and Harry M. Lander, Ph.D. Senior Scientific Consultant

    1:45 - 2:15

    Nature's Miracle Holding, Inc. (NASDAQ:NMHI)

    Keynote speakers: James Li, CEO, and George Yutuc, CFO

    2:55 – 3:05

    Unusual Machines, Inc. (NYSE:UMAC)

    Keynote speaker: Allan Evans, CEO

    3:10 - 3:20

    Peninsula Energy Limited (OTCQB:PENMF) (ASX: PEN)

    Keynote speaker: Wayne W. Heili, MD, CEO & Director

    3:25 - 3:35

    Sucro Limited (OTCQB:SUGRF) (TSXV:SUG)

    Keynote speaker: Don Hill, Chairman

    3:40 – 3:50

    Immuron Limited (NASDAQ:IMRN)

    Keynote speaker: Steve Lydeamore, CEO

    3:55 – 4:05

    LeddarTech Holdings, Inc. (NASDAQ:LDTC) 

    Keynote speakers: Frantz Saintellemy – CEO, and Chris Stewart, CFO

    4:10 – 4:20

    Cyios Corp. (OTC:CYIO) 

    Keynote speaker: John O'Shea, Chairman

    4:25 – 4:35

    Targa Exploration Corp. (CSE:TEX) (OTCQB:TRGEF)

    Keynote speaker: Cameron Tymstra, President & CEO

    4:40 – 4:50

    Stillwater Critical Minerals (TSXV:PGE) (OTCQB:PGEZF) 

    Keynote speaker: Michael Rowley, President & CEO

    Visit the following link to register. You will then receive an email containing the link and time to sign into the conference.

    Register for the Conference here.

    Submit Questions for any of the presenting companies to:

    [email protected]

    Replays: Subscribe to our YouTube Channel

    About EmergingGrowth.com

    Founded in 2009, Emerging Growth.com quickly became a leader in its space and has developed an extensive history of identifying emerging growth companies that can be overlooked by the investment community.

    About the Emerging Growth Conference

    The Emerging Growth Conference is an effective way for public companies to engage with the investment community regarding their Company, new products, services and other major announcements from anywhere, in an effective and time efficient manner.

    All sessions are conducted through video webcasts. Our conference serves as a vehicle for Emerging Growth to build relationships with our existing and potential clients. Accordingly, a certain number of the presenting companies are our current clients, and some may become our clients in the future. In exchange for services we provide, our clients pay us fees in the form of cash and securities, and we may currently have, or in the future may have investments in the securities of certain of the presenting companies. Finally, certain of the presenting companies have paid us a fee to secure a presentation time slot or to present generally. The presentations to be delivered by the presenting companies (including any virtual handouts of written materials) have not been approved, endorsed by or otherwise reviewed by EmergingGrowth.com nor should they in any way be construed to have been made in connection with an offer to sell or a solicitation of an offer to buy securities. Please consult an investment professional before investing in anything viewed on the Emerging Growth Conference or on EmergingGrowth.com.

    If you believe or know of a company that might fit our audience, contact us here.

    Thank you for your interest in our conference, and we look forward to your participation in future conferences.

    Contact:

    Emerging Growth

    Phone: 1-305-330-1985

    Email: [email protected]



    Primary Logo

    Get the next $CIA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CIA
    $CVKD
    $ELUT
    $EUDA

    CompanyDatePrice TargetRatingAnalyst
    GeoVax Labs Inc.
    $GOVX
    2/19/2026Buy → Hold
    D. Boral Capital
    Gossamer Bio Inc.
    $GOSS
    1/28/2026$9.00Overweight
    Barclays
    Gossamer Bio Inc.
    $GOSS
    9/10/2025$9.00Neutral → Buy
    UBS
    Unusual Machines Inc.
    $UMAC
    8/19/2025$15.00Buy
    Needham
    Gossamer Bio Inc.
    $GOSS
    7/14/2025$11.00Sector Outperform
    Scotiabank
    SunCar Technology Group Inc.
    $SDA
    6/10/2025$3.50Outperform
    Oppenheimer
    GeoVax Labs Inc.
    $GOVX
    4/15/2025$18.00 → $14.00Buy
    D. Boral Capital
    GeoVax Labs Inc.
    $GOVX
    4/15/2025$15.00 → $8.50Buy
    Alliance Global Partners
    More analyst ratings

    $CIA
    $CVKD
    $ELUT
    $EUDA
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    December 23, 2021 - FDA Authorizes Marketing of Tobacco Products that Help Reduce Exposure to and Consumption of Nicotine for Smokers Who Use Them

    For Immediate Release: December 23, 2021 Today, the U.S. Food and Drug Administration authorized the marketing of 22nd Century Group Inc.’s “VLN King” and “VLN Menthol King” combusted, filtered cigarettes as modified risk tobacco products (MRTPs), which help reduce exposure to, and consumption of, nicotine for smokers who use them. These are the first combusted cigarettes to be authorized as MRTPs and the second

    12/23/21 9:06:12 AM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    $CIA
    $CVKD
    $ELUT
    $EUDA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    GeoVax Labs downgraded by D. Boral Capital

    D. Boral Capital downgraded GeoVax Labs from Buy to Hold

    2/19/26 8:44:06 AM ET
    $GOVX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Barclays initiated coverage on Gossamer Bio with a new price target

    Barclays initiated coverage of Gossamer Bio with a rating of Overweight and set a new price target of $9.00

    1/28/26 7:16:48 AM ET
    $GOSS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Gossamer Bio upgraded by UBS with a new price target

    UBS upgraded Gossamer Bio from Neutral to Buy and set a new price target of $9.00

    9/10/25 7:56:26 AM ET
    $GOSS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CIA
    $CVKD
    $ELUT
    $EUDA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Rakin Kevin bought $74,200 worth of shares (70,000 units at $1.06), increasing direct ownership by 56% to 196,120 units (SEC Form 4)

    4 - ELUTIA INC. (0001708527) (Issuer)

    2/2/26 5:01:40 PM ET
    $ELUT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Director Neels Guido J bought $20,800 worth of shares (20,000 units at $1.04), increasing direct ownership by 20% to 118,750 units (SEC Form 4)

    4 - ELUTIA INC. (0001708527) (Issuer)

    2/2/26 8:43:47 AM ET
    $ELUT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Director Neels Guido J bought $31,800 worth of shares (30,000 units at $1.06), increasing direct ownership by 44% to 98,750 units (SEC Form 4)

    4 - ELUTIA INC. (0001708527) (Issuer)

    1/29/26 5:51:15 PM ET
    $ELUT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $CIA
    $CVKD
    $ELUT
    $EUDA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    $CIA
    $CVKD
    $ELUT
    $EUDA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    $CIA
    $CVKD
    $ELUT
    $EUDA
    SEC Filings

    View All

    SEC Form 4 filed by Chief Financial Officer Sullivan James

    4 - Peraso Inc. (0000890394) (Issuer)

    2/10/26 4:51:50 PM ET
    $PRSO
    Semiconductors
    Technology

    SEC Form 4 filed by Chief Executive Officer Glibbery Ronald

    4 - Peraso Inc. (0000890394) (Issuer)

    2/10/26 4:51:37 PM ET
    $PRSO
    Semiconductors
    Technology

    SEC Form 4 filed by Chief Operating Officer Lynch Brad

    4 - Peraso Inc. (0000890394) (Issuer)

    2/10/26 4:51:25 PM ET
    $PRSO
    Semiconductors
    Technology

    Safe Pro Group Projects Over 500% Year-Over-Year Q1 2026 Revenue Growth Following U.S. Government Award for AI Edge Processing Systems

    AVENTURA, Fla., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Safe Pro Group Inc. (NASDAQ:SPAI) ("Safe Pro" or the "Company"), an artificial intelligence ("AI") defense technology company delivering drone-powered situational awareness and threat detection solutions, today announced that it expects revenue in the first quarter of 2026 to increase over 500% year-over-year, driven by initial deliveries under a recently awarded U.S. Government subcontract supporting deployment of the Company's AI-Powered Edge Processing platform. The Company believes it is entering a commercial and government adoption inflection point, transitioning from development-stage operations into scaling revenue generation and op

    2/23/26 8:05:00 AM ET
    $ONDS
    $SPAI
    $UMAC
    Radio And Television Broadcasting And Communications Equipment
    Technology
    Industrial Specialties
    Health Care

    Gossamer Bio Announces Topline Results from the Phase 3 PROSERA Study Evaluating Seralutinib in Pulmonary Arterial Hypertension

    - Seralutinib demonstrated a placebo-adjusted improvement in Six-Minute Walk Distance (6MWD) of +13.3 meters at Week 24 (p = 0.0320), missing the prespecified alpha threshold of 0.025 - - At week 24, patients receiving seralutinib had a median change of +28.2 meters from baseline, while patients receiving placebo had a median change from baseline of +13.5 meters - - Consistent with the TORREY Study, prespecified intermediate and high-risk subgroup (n = 234) showed a +20.0 meter placebo-adjusted 6MWD improvement (p = 0.0207), with 3 of 4 key secondary endpoints achieving p < 0.0125 - - Overall treatment effect was most pronounced in North America (n = 75), with a +25.9m placebo-adjuste

    2/23/26 8:00:00 AM ET
    $GOSS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    22nd Century Group Preliminarily Reports Fourth Quarter and Full Year 2025 Financial Results

    Balance sheet strength, ended 2025 with $7.1 million in cash and debt free, supports transition to growth Continued VLN® commercial expansion drives shift toward higher margin proprietary branded products MOCKSVILLE, N.C., Feb. 20, 2026 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NASDAQ:XXII), the only tobacco products company that has for 27 years led and continues to lead the fight against the harms of smoking driven by nicotine addiction, today announced select, preliminary and unaudited financial results and operating metrics for the fourth quarter and full year ended December 31, 2025. The company anticipates releasing fourth quarter and full year 2025 earnings on or before March

    2/20/26 4:15:00 PM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    Gossamer Bio Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - Gossamer Bio, Inc. (0001728117) (Filer)

    2/23/26 8:30:24 AM ET
    $GOSS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by Nova Minerals Limited

    6-K - Nova Minerals Ltd (0001852551) (Filer)

    2/23/26 6:45:03 AM ET
    $NVA
    Precious Metals
    Basic Materials

    22nd Century Group Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits

    8-K - 22nd Century Group, Inc. (0001347858) (Filer)

    2/20/26 4:15:28 PM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    $CIA
    $CVKD
    $ELUT
    $EUDA
    Financials

    Live finance-specific insights

    View All

    Gossamer Bio Announces Topline Results from the Phase 3 PROSERA Study Evaluating Seralutinib in Pulmonary Arterial Hypertension

    - Seralutinib demonstrated a placebo-adjusted improvement in Six-Minute Walk Distance (6MWD) of +13.3 meters at Week 24 (p = 0.0320), missing the prespecified alpha threshold of 0.025 - - At week 24, patients receiving seralutinib had a median change of +28.2 meters from baseline, while patients receiving placebo had a median change from baseline of +13.5 meters - - Consistent with the TORREY Study, prespecified intermediate and high-risk subgroup (n = 234) showed a +20.0 meter placebo-adjusted 6MWD improvement (p = 0.0207), with 3 of 4 key secondary endpoints achieving p < 0.0125 - - Overall treatment effect was most pronounced in North America (n = 75), with a +25.9m placebo-adjuste

    2/23/26 8:00:00 AM ET
    $GOSS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    22nd Century Group Preliminarily Reports Fourth Quarter and Full Year 2025 Financial Results

    Balance sheet strength, ended 2025 with $7.1 million in cash and debt free, supports transition to growth Continued VLN® commercial expansion drives shift toward higher margin proprietary branded products MOCKSVILLE, N.C., Feb. 20, 2026 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NASDAQ:XXII), the only tobacco products company that has for 27 years led and continues to lead the fight against the harms of smoking driven by nicotine addiction, today announced select, preliminary and unaudited financial results and operating metrics for the fourth quarter and full year ended December 31, 2025. The company anticipates releasing fourth quarter and full year 2025 earnings on or before March

    2/20/26 4:15:00 PM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    Intelligent Bio Solutions Reports Record Fiscal Second Quarter Revenue Growth of 48% with Reader Sales Surging 104% Year-Over-Year

    First half fiscal 2026 revenue surpasses $2 million, up 36% year-over-year  Reader sales more than double to 104% year-over-year for the second quarter, demonstrating razor-razorblade model momentum Gross profit margins for first half fiscal 2026 increased 10% year-over-year to 49%, reflecting improved operational efficiency Current assets balance of $12.17 million as of December 31, 2025, including $9.40 million receivable in connection with the private placement of securities that closed on January 2, 2026. NEW YORK, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (NASDAQ:INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, no

    2/12/26 8:30:00 AM ET
    $INBS
    Medical/Dental Instruments
    Health Care

    $CIA
    $CVKD
    $ELUT
    $EUDA
    Leadership Updates

    Live Leadership Updates

    View All

    Military UAV Sector Forecast to Surpass $40+ Billion as Modern Warfare Evolves

    NEW YORK, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Market News Updates News Commentary - Unmanned aerial vehicles (UAVs), commonly known as drones, have become a transformative technology in modern defense and military operations, reshaping strategies from reconnaissance to precision strike capabilities. Military drones offer armed forces enhanced situational awareness, reduced risk to personnel, and cost-efficient mission profiles across surveillance, target acquisition, logistics, and electronic warfare. As autonomous systems incorporating artificial intelligence and advanced sensor suites continue to mature, they are increasingly integral to networked battlefield operations and force multiplie

    2/19/26 8:30:00 AM ET
    $NOC
    $PRZO
    $UAVS
    Industrial Machinery/Components
    Industrials
    Military/Government/Technical
    Aerospace

    Where Purpose Meets Performance: Elutia Earns 2026 Great Place to Work Certification™

    GAITHERSBURG, Md., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Elutia Inc. (NASDAQ:ELUT) ("Elutia" or the "Company"), a pioneer in drug-eluting biomatrix technologies, today announced that it has been Certified™ by Great Place to Work®, the leading organization that evaluates workplace culture through a standardized, anonymous employee survey methodology developed over 30 years of research. The certification recognizes organizations with high-trust workplace cultures, where sustained engagement and retention support consistent execution in regulated, innovation-driven industries. "Elutia isn't for everyone," said Dana Yoo, PhD, VP of Product Development. "The bar is high, and the work is hard. But

    2/18/26 8:00:00 AM ET
    $ELUT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Nature's Miracle Holding Inc. Appoints Dr. Jinlong "Frank" Du as President of Agricultural Business

    ONTARIO, Calif., Feb. 4, 2026 /PRNewswire/ -- Nature's Miracle Holding Inc. (OTCQB:NMHI) today announced the appointment of Dr. Jinlong "Frank" Du as President of the Company's Agricultural Business. Dr. Du is a globally recognized entrepreneur and technology leader in indoor growing and controlled environment agriculture ("CEA"), with more than 20 years of experience in modern CEA and advanced facility agriculture. He is the founder and former Chief Executive Officer of Megaphoton, Inc., a technology company specializing in advanced horticultural lighting and integrated green

    2/4/26 8:30:00 AM ET
    $NMHI
    Industrial Machinery/Components
    Industrials

    $CIA
    $CVKD
    $ELUT
    $EUDA
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    $CIA
    $CVKD
    $ELUT
    $EUDA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Insider Analysis: Purchase at Gossamer Bio Inc. on Jun 21

    Gossamer Bio Inc. recently witnessed an insider purchase by COO/CFO Bryan Giraudo, who acquired $59,110 worth of shares consisting of 100,000 units at $0.59 per share. Insider purchases like this can provide valuable insights for investors, indicating confidence from individuals within the company about its future prospects. Examining previous insider transactions, on 2024-03-19, insiders Peterson Caryn and Aranda Richard each sold $5,343 worth of shares at $1.33, leading to a decrease in their direct ownership percentages. Similarly, on 2024-03-28, Hasnain Faheem, Giraudo Bryan, and Christian Waage sold shares worth $26,773, $7,431, and $7,430, respectively, impacting their direct ownershi

    6/21/24 3:17:31 PM ET
    $GOSS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by Pure Cycle Corporation

    SC 13D/A - PURE CYCLE CORP (0000276720) (Subject)

    12/5/24 6:15:44 PM ET
    $PCYO
    Water Supply
    Utilities

    Amendment: SEC Form SC 13G/A filed by 22nd Century Group Inc.

    SC 13G/A - 22nd Century Group, Inc. (0001347858) (Subject)

    12/3/24 11:18:54 AM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    Amendment: SEC Form SC 13D/A filed by Nature's Miracle Holding Inc.

    SC 13D/A - Nature's Miracle Holding Inc. (0001947861) (Subject)

    11/21/24 4:11:43 PM ET
    $NMHI
    Industrial Machinery/Components
    Industrials